BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28110871)

  • 1. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
    Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
    Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
    Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
    Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A
    Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH; Zaki MA
    Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
    Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents.
    Du H; Tian S; Chen J; Gu H; Li N; Wang J
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4015-9. PubMed ID: 27397495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
    Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.
    Lu Y; Yan Y; Wang L; Wang X; Gao J; Xi T; Wang Z; Jiang F
    Eur J Med Chem; 2017 Feb; 127():928-943. PubMed ID: 27836197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of novel 2-substituted indoline imidazolium salt derivatives.
    Xu XL; Yu CL; Chen W; Li YC; Yang LJ; Li Y; Zhang HB; Yang XD
    Org Biomol Chem; 2015 Feb; 13(5):1550-7. PubMed ID: 25491254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
    Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
    J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities.
    Ding J; Liu J; Zhang Z; Guo J; Cheng M; Wan Y; Wang R; Fang Y; Guan Z; Jin Y; Xie SS
    Bioorg Chem; 2020 Aug; 101():104023. PubMed ID: 32650178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
    Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
    Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
    Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S
    Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
    Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
    Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.
    Yeap S; Akhtar MN; Lim KL; Abu N; Ho WY; Zareen S; Roohani K; Ky H; Tan SW; Lajis N; Alitheen NB
    Drug Des Devel Ther; 2015; 9():983-92. PubMed ID: 25733816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.